Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0C1OJ
|
||||
| Former ID |
DIB011831
|
||||
| Drug Name |
Debio-0930
|
||||
| Synonyms |
MT-63-78; AMPK stimulator (oral, cancer), Mercury Therapeutics/Debiopharm SA; Adenosine monophosphate activated protein kinase stimulator (oral, cancer), Mercury Therapeutics/Debiopharm SA
|
||||
| Indication | Metabolic disorders [ICD9: 270-279; ICD10:E70-E89] | Investigative | [543438] | ||
| Company |
Mercury Therapeutics Inc
|
||||
| Target and Pathway | |||||
| Target(s) | AMP-activated protein kinase | Target Info | Stimulator | [543438] | |
| KEGG Pathway | FoxO signaling pathway | ||||
| Regulation of autophagy | |||||
| mTOR signaling pathway | |||||
| PI3K-Akt signaling pathway | |||||
| AMPK signaling pathway | |||||
| Circadian rhythm | |||||
| Insulin signaling pathway | |||||
| Adipocytokine signaling pathway | |||||
| Oxytocin signaling pathway | |||||
| Glucagon signaling pathway | |||||
| Non-alcoholic fatty liver disease (NAFLD) | |||||
| Hypertrophic cardiomyopathy (HCM) | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.